This site contains information about prescription peptide therapy protocols intended for adults. You must be 18 years of age or older to enter.
By entering, you confirm you are at least 18 years old and agree to our Terms of Service. All protocols require a valid physician prescription.
A synthetic fragment of the naturally occurring protein thymosin beta-4, studied for its role in accelerating tissue repair, tendon healing, and injury recovery through cellular migration and angiogenesis pathways.
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 — a protein found in virtually every cell in the human body. Specifically, TB-500 replicates the LKKTETQ amino acid sequence that is responsible for thymosin beta-4's ability to bind actin, the structural protein that governs cell shape and movement.
Thymosin beta-4 was first identified in the thymus gland and later found to play a central role in wound healing, cell migration, and the formation of new blood vessels (angiogenesis). The TB-500 fragment isolates the biologically active portion of this protein, making it a more targeted research compound.
It is among the most widely used recovery peptides in the research community, frequently paired with BPC-157 as a synergistic healing stack. Its primary areas of study include tendon and ligament repair, muscle fiber regeneration, and reduction of inflammation at injury sites.
TB-500's LKKTETQ sequence binds G-actin, promoting cell migration into damaged tissue — the critical first step in injury repair.
Studied extensively for accelerating recovery from tendon injuries, ligament tears, and connective tissue damage through enhanced fibroblast activity.
Promotes the formation of new blood vessels at injury sites, increasing oxygen and nutrient delivery to accelerate tissue regeneration.
Supports satellite cell activation and muscle fiber repair following strain, overuse, or training stress — used by athletes targeting faster return to performance.
Reduces local inflammation at injury sites by modulating cytokine activity and oxidative stress, supporting a cleaner healing environment.
Research models show support for joint tissue integrity, with potential applications in cartilage protection alongside tendon and ligament healing.
TB-500 is typically administered via subcutaneous injection, with some protocols using intramuscular injection near the injury site. A loading phase followed by a maintenance phase is the standard community-observed structure.
TB-500 is frequently stacked with BPC-157 — the two peptides work through complementary pathways, with BPC-157 driving local tissue repair and TB-500 driving systemic cell migration and angiogenesis.
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Loading | 2.0 – 2.5 mg | Twice weekly | 4 – 6 weeks |
| Maintenance | 2.0 mg | Once weekly | 4 – 8 weeks |
| Route | Subcutaneous (SC) — abdomen, upper thigh, or near injury site | ||
| Storage | Lyophilized: refrigerate. Reconstituted: use within 30 days, keep refrigerated. | ||
TB-500's biology is grounded in thymosin beta-4 research, a well-studied protein with publications spanning wound healing, cardioprotection, ophthalmology, and neurology. The TB-500 fragment targets the same LKKTETQ actin-binding region that makes thymosin beta-4 biologically active.
Thymosin beta-4 formulations have shown positive results in human wound healing studies, including eye surface healing in ophthalmology applications, establishing the base biology that TB-500 research draws from.
The LKKTETQ sequence has been mapped as the critical actin-binding site of thymosin beta-4, explaining its capacity to mobilize cells into injured tissue — the foundational mechanism of TB-500.
Preclinical studies in animal models show accelerated tendon repair, reduced fibrosis, and faster return of mechanical strength in injured connective tissue treated with thymosin beta-4 / TB-500.
Thymosin beta-4 has shown cardioprotective and neuroprotective effects in animal models, suggesting TB-500's cell migration pathway may have systemic applications beyond musculoskeletal repair.
TB-500 and BPC-157 are the most recognized recovery stack in peptide research — complementary mechanisms, often run simultaneously for injuries requiring both local repair and systemic healing support.
BPC-157 works primarily through local receptor signaling (VEGFR2, nitric oxide pathways) and tends to be used near the injury site. TB-500 works systemically — its LKKTETQ sequence drives cell migration and angiogenesis throughout the body. Many researchers run them together because the mechanisms are additive, not redundant.
TB-500 is thought to have systemic distribution, so subcutaneous injection anywhere (abdomen, thigh) is reported to reach injury sites. Some protocols prefer injection closer to the injury for higher local concentration, but this is a matter of ongoing debate in the research community. Standard subcutaneous is the most common approach.
Anecdotal reports from the research community suggest 2–4 weeks into the loading phase before meaningful changes in injury recovery or inflammation are noticed. The full course typically runs 8–12 weeks total (loading + maintenance).
Research has focused primarily on injury and wound healing applications. Some researchers use TB-500 post-training for general recovery acceleration, citing its anti-inflammatory and angiogenic properties. This is an off-label community use, not an established clinical protocol.
Third-party tested purity of ≥99% is the standard. Cinch Bio uses Finnrick Analytics-verified suppliers with batch-specific COAs available on request. Always verify purity documentation before using any peptide product.
TB-500 is sold for research purposes only. It has not been approved by the FDA for human use, and the information on this page is educational in nature and does not constitute medical advice. Consult a qualified healthcare professional before considering any peptide protocol. Individual results vary. Do not use peptides without proper medical supervision.
Third-party tested TB-500 with Finnrick Analytics verification. Full COA on every batch. Ships within 24 hours.
Get Started TodayMedical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All protocols require evaluation and prescription by a licensed physician. You should consult a qualified healthcare provider before starting any new medical protocol. Individual results vary. Cinch Bio is not a pharmacy and does not dispense medications — all prescriptions are issued by independent licensed physicians and filled by licensed 503A compounding pharmacies.